AB Science S.A. Profile Avatar - Palmy Investing

AB Science S.A.

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III cl…

Drug Manufacturers - Specialty & Generic
FR, Paris [HQ]

Cash Flow Statements

AB.PA in €
In
Mil.
except specified
3Y 10Y 20Y 40Y
AB.PA SRC
Cash Flow from Operating Activities
Depreciation and Amortization
Deferred Taxes
Stock Based Compensation
Change in Working Capital
Change in Accounts Payable
Cash Flow from Investing Activities
Capital Expenditures
Acquisitions (Net)
Investments (Purchases)
Sales/Maturities of Investments
Other Investing Activities
Cash Flow from Financing Activities
Issuance of Debt
Repayment of Debt
Dividends Paid
Stock-Based Compensation (Financing Activity)
Other Financing Activities
Net Change in Cash
Cash at Beginning of Period
Effect of Forex Changes on Cash
Cash at End of Period
End of AB.PA's Analysis
CIK: - CUSIP: - ISIN: FR0010557264 LEI: - UEI: -
Secondary Listings
AB.PA has no secondary listings inside our databases.